期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
New scoring system for acute chest pain risk stratification: Is it worth SVEAT-ing it?
1
作者 Mahati Dasari Pramukh Arun Kumar +1 位作者 Yuvaraj Singh Eddison Ramsaran 《World Journal of Cardiology》 2023年第4期200-204,共5页
The emergency room is a very potent environment in the hospital.With the growing demands of the population,improved accessibility to health resources,and the onslaught of the triple pandemic,it is extremely crucial to... The emergency room is a very potent environment in the hospital.With the growing demands of the population,improved accessibility to health resources,and the onslaught of the triple pandemic,it is extremely crucial to triage patients at presentation.In the spectrum of complaints,chest pain is the commonest.Despite it being a daily ailment,chest pain brings concern to every physician at first.Chest pain could span from acute coronary syndrome,pulmonary embolism,and aortic dissection(all potentially fatal)to reflux,zoster,or musculoskeletal causes that do not need rapid interventions.We often employ scoring systems such as GRACE/PURSUIT/TIMI to assist in clinical decision-making.Over the years,the HEART score became a popular and effective tool for predicting the risk of 30-d major adverse cardiovascular events.Recently,a new scoring system called SVEAT was developed and compared to the HEART score.We have attempted to summarize how these scoring systems differ and their generalizability.With an increasing number of scoring systems being introduced,one must also prevent anchorage bias;i.e.,tools such as these are only diagnosis-specific and not organ-specific,and other emergent differential diagnoses must also be kept in mind before discharging the patient home without additional workup. 展开更多
关键词 Chest pain Acute coronary syndrome sveat score HEART score TIMI score Risk stratification scores
暂未订购
蛇毒抗栓酶对原发性高血压患者甲皱微循环及血液流变学影响的观察
2
作者 刘学源 张孝忠 《潍坊医学院学报》 1989年第2期8-10,共3页
对50例不同期的原发性高血压患者应用蛇毒抗栓酶进行治疗,治疗前后分别进行了甲皱微循环及血液流变学观察,结果表明:蛇毒抗栓酶可显著改善患者的甲皱微循环,主要表现为管袢较前清晰,袢顶渗出、扩张显著减轻、输入动脉与输出静脉之比恢... 对50例不同期的原发性高血压患者应用蛇毒抗栓酶进行治疗,治疗前后分别进行了甲皱微循环及血液流变学观察,结果表明:蛇毒抗栓酶可显著改善患者的甲皱微循环,主要表现为管袢较前清晰,袢顶渗出、扩张显著减轻、输入动脉与输出静脉之比恢复正常,血流加速,流态明显改善。血液流变学亦有明显改善,临床症状好转。 展开更多
关键词 蛇毒抗栓酶 微循环 血液流变学 高血压
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部